Drugs / AI201901
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04729517 | Apr 2021 → Mar 2023 | allergic rhinitis | Abdi Ibrahim Ilac San. ve Tic A.S. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AI201901 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04729517 ↗ |
| Route | Inhaled | “Twice daily inhaled AI201901 for 4 weeks” NCT04729517 ↗ |